to IMGT/mAb-DB
database logo
1417 entries
1234 -IG
7 -TR
47 -FPIA
68 -CPCA
61 -RPI

IMGT/mAb-DB card

Version: 2.0.4 (2023-04-14)

Citing IMGT/mAb-DB

Manso T., Kushwaha A., Abdollahi N., Duroux P., Giudicelli V. and Kossida S. Mechanisms of action of monoclonal antibodies in oncology integrated in IMGT/mAb-DB. Front Immunol., 14 (2023). DOI 10.3389/fimmu.2023.1129323

Poiron C., Wu Y., Ginestoux C., Ehrenmann, Duroux P. and Lefranc M.-P. IMGT/mAb-DB: the IMGT® database for therapeutic monoclonal antibodies. JOBIM 2010, Paper 13 (2010). Abstract PDF

Cambon M., Cherouali K., Kushwaha A., Giudicelli V., Duroux P., Kossida S. and Lefranc M.-P. IMGT/mAb-DB and IMGT/2Dstructure-DB for IMGT standard definition of an antibody: from receptor to amino acid changes. JOBIM 2018, Poster 201 (2018). Abstract PDF

IMGT/mAb-DB ID 361
INN enokizumab
INN Number 9262
INN Prop. List 104 (2010)
INN Rec. List 66 (2011)
Common name 7F3com-2H2, MEDI-528
Proprietary name
Species Humanized
IMGT receptor type IG
Format (legend)
Receptor identification IgG1 - kappa
Radiolabelled / Conjugated / Fused
IMGT/2Dstructure-DB 9262
Specificity target name and species IL9 (interleukin 9, IL-9, T cell growth factor p40) [Humanized]
Development Technology
Origin clone species
Origin clone name

Company MedImmune (Gaithersburg MD USA); AstraZeneca (London UK)
Expression system
Application Therapeutic
Clinical domain Immunology
Mechanism of action
Clinical indication Asthma
Development status Phase II
Regulatory agency status and year

    Clinical trials
    Authority decisions
      External links
      IMGT notes
      IMGT references
      • Antoniu SA, et al., Curr. Opin. Mol. Ther. 2010; 12(2):233-9. PMID: 20373267
        Format legend:

        © Copyright 1995-2023 IMGT®, the international ImMunoGeneTics information system® | Terms of use | About us | Contact us | Citing IMGT
        European Commission umontpellier CNRS